Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beauty Health (SKIN) EBITDA (2021 - 2025)

Historic EBITDA for Beauty Health (SKIN) over the last 5 years, with Q3 2025 value amounting to -$10.6 million.

  • Beauty Health's EBITDA rose 3796.77% to -$10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.8 million, marking a year-over-year increase of 6337.7%. This contributed to the annual value of -$33.0 million for FY2024, which is 6652.37% up from last year.
  • Per Beauty Health's latest filing, its EBITDA stood at -$10.6 million for Q3 2025, which was up 3796.77% from $23.3 million recorded in Q2 2025.
  • Over the past 5 years, Beauty Health's EBITDA peaked at $31.3 million during Q1 2022, and registered a low of -$216.7 million during Q3 2021.
  • In the last 5 years, Beauty Health's EBITDA had a median value of -$7.3 million in 2023 and averaged -$24.4 million.
  • Its EBITDA has fluctuated over the past 5 years, first skyrocketed by 529824.21% in 2022, then plummeted by 426290.04% in 2023.
  • Beauty Health's EBITDA (Quarter) stood at -$20.6 million in 2021, then surged by 142.27% to $8.7 million in 2022, then crashed by 184.06% to -$7.3 million in 2023, then plummeted by 84.97% to -$13.6 million in 2024, then increased by 21.82% to -$10.6 million in 2025.
  • Its EBITDA was -$10.6 million in Q3 2025, compared to $23.3 million in Q2 2025 and -$9.0 million in Q1 2025.